Celcuity LLC (CELC)

NASDAQ
Currency in USD
10.53
-0.32(-2.95%)
Closed
After Hours
10.530.00(0.00%)
CELC Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
10.4211.30
52 wk Range
10.3522.19
Key Statistics
Edit
Prev. Close
10.85
Open
11.02
Day's Range
10.42-11.3
52 wk Range
10.35-22.19
Volume
303.69K
Average Vol. (3m)
275.79K
1-Year Change
-26.72%
Book Value / Share
4.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CELC Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
28.86
Upside
+174.05%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory
Show more

Celcuity LLC Company Profile

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company’s CELsignia diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular process driving a patient’s cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Compare CELC to Peers and Sector

Metrics to compare
CELC
Peers
Sector
Relationship
P/E Ratio
−4.2x−3.7x−0.6x
PEG Ratio
−0.85−0.140.00
Price / Book
2.6x2.9x2.6x
Price / LTM Sales
-13.8x3.1x
Upside (Analyst Target)
156.2%283.5%55.2%
Fair Value Upside
Unlock36.1%9.8%Unlock

Analyst Ratings

8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 28.86

(+174.05% Upside)

Earnings

Latest Release
Nov 14, 2024
EPS / Forecast
-0.65 / -0.65
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

31.36
VLGEA
-1.51%
182.77
CRAI
+1.98%
111.44
IOSP
+3.26%
10.14
EVCM
+0.30%
14.11
CMPO
+2.17%

FAQ

What Is the Celcuity (CELC) Stock Price Today?

The Celcuity stock price today is 10.53

What Stock Exchange Does Celcuity Trade On?

Celcuity is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Celcuity?

The stock symbol for Celcuity is "CELC."

What Is the Celcuity Market Cap?

As of today, Celcuity market cap is 390.97M.

What is Celcuity Earnings Per Share?

The Celcuity EPS is -2.61.

What Is the Next Celcuity Earnings Date?

Celcuity will release its next earnings report on Mar 20, 2025.

From a Technical Analysis Perspective, Is CELC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.